MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic <i>E. coli</i> in Experimental Urinary Tract Infection

MV140 is an inactivated whole-cell bacterial mucosal vaccine with proven clinical efficacy against recurrent urinary tract infections (UTIs). These infections are primarily caused by uropathogenic <i>E. coli</i> (UPEC) strains, which are unique in their virulence factors and remarkably diverse. MV14...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Paula Saz-Leal, Marianne Morris Ligon, Carmen María Diez-Rivero, Diego García-Ayuso, Soumitra Mohanty, Marcos Viñuela, Irene Real-Arévalo, Laura Conejero, Annelie Brauner, José Luis Subiza, Indira Uppugunduri Mysorekar
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2024-05-01
Sarja:	Vaccines
Aiheet:	MV140 UTI89 mucosal immunity vaccine UTI—urinary tract infection UPEC—uropathogenic <i>E. coli</i>
Linkit:	https://www.mdpi.com/2076-393X/12/5/535
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!